The New York Academy of Medicine

CASE
HOMEPAGE

2002 HRSA RWC CONFERENCE

CASE STUDY ABSTRACT, OBJECTIVES & DESIGN

CASE STUDY AMENDMENT: IMPACT OF 9/11 ON PWH/As TAKING HAART

CASE STAFF & GRANTEE ROSTER

DATA COLLECTION TOOLS

CASE STUDY DATA ANALYSIS PLAN

DISSEMINATION ACTIVITIES

RESOURCES & LINKS

  

CASE
The Center for Adherence Support Evaluation
at the New York Academy of Medicine


A Multi-Method Approach to Measuring Antiretroviral Therapy (ART) Adherence from the Cross-Site New York Academy of Medicine Center for Adherence Support Evaluation /HRSA SPNS Adherence Collaboration

Background: High rates of adherence to ART is critical to success with treatment. However, the optimal measure of adherence in clinical practice is still unknown.

Methods: As part of the New York Academy of Medicine/ HRSA initiative, we are evaluating the impact of 13 adherence support programs. Adherence was measured using 3-day self-report, last time missed and number of days/week with a missed dose. Baseline adherence data from the 312 patients from 8 of the 13 sites on ART at enrollment were used in these analyses to evaluate the relationship among different adherence measures. Data were collected through face-to-face interviews using a standardized adherence questionnaire.

Results: The sample was 39% female, 68% minority; 47% reported mental illness and 16% active drug use. Only 29% had a viral load <400 at baseline.

Nonadherence (>1 dose missed) by 3-day recall correlated with frequency of days/week with a missed dose (p=.001), difficulty taking medications on time (p=.001), and last time missed dose (p=.001). Presence and number of side effects predicted adherence (p=.001).
No correlation was seen between nonadherence on 3-day recall and the following baseline measures: difficulty following special instructions, health status, number, class or specific ART, or baseline viral load and CD4 count.

Measure
Missed>1 dose on baseline 3 day recall
No missed dose on 3 day recall
P value
Days/week with missed dose=0/<1 per week
28%
81%
.001
Last time missed=never/>1mo
3%
66%
.001
Difficulty taking on time=never/rarely
58%
88%
.001
ARV-related side effect
61%
28%
.001
"A lot" of difficulty taking ART due to side effects
23%
3%
.001

Conclusions: Correlations between a number of self-report adherence measures were found in this diverse multi-site population. As more data are collected, we will be able to develop a composite adherence measure to improve accuracy of adherence assessment in the field.


CASE
The New York Academy of Medicine
1216 Fifth Avenue
New York, NY 10029
(212) 822-7237

Last updated: 4/11/02